The Medicines Company brings out the ax, looking to jettison hundreds of jobs in top-to-bottom restructuring
The Medicines Company CEO Clive Meanwell is circling all the wagons around its late-stage PCSK9 development plans for inclisiran.
The Alnylam partner said today that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
